CO4.2 - Cost-effectiveness of an adaptive radiotherapy strategy to decrease xerostomia in locally advanced oropharynx carcinoma: An economic evaluation alongside the ARTIX Randomized Clinical Trial matched to the French National Health Insurance Database - Archive ouverte HAL Accéder directement au contenu
Communication Dans Un Congrès Année : 2023

CO4.2 - Cost-effectiveness of an adaptive radiotherapy strategy to decrease xerostomia in locally advanced oropharynx carcinoma: An economic evaluation alongside the ARTIX Randomized Clinical Trial matched to the French National Health Insurance Database

Fichier non déposé

Dates et versions

hal-04284994 , version 1 (14-11-2023)

Identifiants

Citer

L. Perrier, F. Balusson, M. Morelle, J. Castelli, E. Oger, et al.. CO4.2 - Cost-effectiveness of an adaptive radiotherapy strategy to decrease xerostomia in locally advanced oropharynx carcinoma: An economic evaluation alongside the ARTIX Randomized Clinical Trial matched to the French National Health Insurance Database. EPICLIN 2023 17e Conférence francophone d’Épidémiologie Clinique30e Journées des statisticiens des Centres de Lutte contre le Cancer, May 2023, Nancy, France. pp.101613-101613, ⟨10.1016/j.respe.2023.101613⟩. ⟨hal-04284994⟩
15 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More